Alveus Therapeutics, Inc.

CIK 2075856 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Alveus Therapeutics, Inc..

Recent SEC filings

FiledFormAccession number
Jan 14, 2026D0001231919-26-000051